Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2005 (Vol. 25, No. 12)


  • Communications options
  • Too little information
The Broad Institute at MIT has a mission to “create tools for genomic medicine and make them broadly available to the scientific community.” The site associated with the institute is rather impressive, but that is not the focus of this report. The software tool they freely distribute called Argo is worth noting all on its own. Written as a Java application (translation—multiplatform), Argo is a tool for visualizing and manually annotating entire genomes. The program can display sequence and annotation tracks from numerous information formats (FASTA, Genbank, GFF, BLAST, and Genscan files). It provides an interactive zoom from megabases down to the nucleotide level. Updates to Argo are made monthly (according to the site). Worth a check, particularly in view of its price—free!
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »